Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;71(4):235-42.
doi: 10.6061/clinics/2016(04)11.

High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities

Affiliations
Review

High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities

Francisco Antonio Helfenstein Fonseca et al. Clinics (Sao Paulo). 2016 Apr.

Abstract

Despite substantial differences in ethnicities, habits, cultures, the prevalence of traditional cardiovascular risk factors and affordable therapies, atherosclerosis remains the major cause of death in developing and developed countries. However, irrespective of these differences, inflammation is currently recognized as the common pathway for the major complications of atherosclerosis, stroke, and ischemic heart disease. A PubMed search was conducted for "high-sensitivity C-reactive protein" (hs-CRP) in combination with the terms race, ethnicity, gender, prevalence, geographic, epidemiology, cardiovascular, obesity, diabetes, hypertension, cholesterol, smoking, ischemic heart disease, stroke, and mortality. This review includes the articles that pertained to the topic and additional articles identified from the reference lists of relevant publications. This review describes the marked differences in cardiovascular mortality across countries and ethnicities, which may be attributed to inequalities in the prevalence of the classic risk factors and the stage of cardiovascular epidemiological transition. However, hs-CRP appears to contribute to the prognostic information regarding cardiovascular risk and mortality even after multiple adjustments. Considering the perception of cardiovascular disease as an inflammatory disease, the more widespread use of hs-CRP appears to represent a valid tool to identify people at risk, independent of their ancestry or geographic region. In conclusion, this review reports that the complications associated with vulnerable atherosclerotic plaques are triggered by the major mechanisms of dyslipidemia and inflammation; whereas both mechanisms are influenced by classic risk factors, hs-CRP contributes additional information regarding cardiovascular events and mortality.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1
Estimated age-standardized death rates (per 100,000) due to ischemic heart disease in individuals of both sexes among Asian, American, African, and European populations according to the World Health Organization . Values for countries with the lowest and highest rates are shown per region.
Figure 2
Figure 2
Estimated age-standardized death rates (per 100,000) due to cerebrovascular disease in individuals of both sexes among Asian, American, African, and European populations according to the World Health Organization . Values for countries with the lowest and highest rates are shown per region.
Figure 3
Figure 3
Increased cholesterol concentrations with oxidized lipoproteins and inflammatory stimuli through the release of cytokines with subsequent increase in C-reactive protein. Both pathways are related to classic risk factors and contribute to the development of and complications associated with vulnerable atherosclerotic plaques. Thus, lipid and high-sensitivity C-reactive protein determinants provide additional information regarding cardiovascular risk. Strategies to control both mechanisms appear germane to decreasing the global cardiovascular disease burden, independent of ethnicity or geographic region.

References

    1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340((2)):115–26. - DOI - PubMed
    1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420((6917)):868–74. - DOI - PubMed
    1. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487((7407)):325–9. - DOI - PMC - PubMed
    1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336((14)):973–9. - DOI - PubMed
    1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342((12)):836–43. - DOI - PubMed

MeSH terms